ARCHIVES

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Cancer Studies In China Intact; Visits Delayed

July 14, 1989

Healy ‘Concerned’ About NCI Budget; ‘Definite Erosion’

May 3, 1991

NIH Acknowledges Role Of Pasteur Virus In AIDS Test, Gives France More Royalties

July 15, 1994

Health Groups Urge FDA To Regulate Tobacco Products, Including E-Cigarettes

September 5, 2014

Abstracts Of Papers For Therapeutic Radiologists Meeting

November 7, 1975

Arzerra Promising For Heavily Pre-Treated CLL Patients

December 26, 2008